| For: | Ng NBH, Sng AA, Huang JG. Fighting the epidemic of pediatric metabolic dysfunction-associated steatotic liver disease: Role of non-invasive diagnostics and early pharmacological intervention. World J Hepatol 2026; 18(1): 111211 [PMID: 41640966 DOI: 10.4254/wjh.v18.i1.111211] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v18/i1/111211.htm |
| Number | Citing Articles |
| 1 |
Ella Findling, Terrence Bissoondial, Prakash Narayan. Glucagon-Like Peptide-1 Receptor Agonists Reduce Liver Stiffness in a Pediatric Metabolic Dysfunction-Associated Liver Disease Cohort and Normalize Disease-Associated Core Gene Expression in an Experimental Model. Cureus 2026; doi: 10.7759/cureus.106280
|
| 2 |
Valeria Calcaterra, Alessandro Gatti, Alessandra Gazzarri, Alice De Lorenzo, Alessandra Maggi, Ester Minardi, Vittoria Carnevale Pellino, Matteo Vandoni, Gianvincenzo Zuccotti. Early metabolic and hepatic alterations in children with Down syndrome: a hidden risk beyond BMI. Journal of Pediatric Endocrinology and Metabolism 2026; doi: 10.1515/jpem-2026-0221
|
| 3 |
Diana Zamosteanu, Nina Filip, Ludmila Lozneanu, Simona Eliza Giusca, Oana Viola Badulescu, Mihaela Pertea, Alexandru Filip, Carmen Ungureanu, Eugenia Morosan, Elena Cojocaru. Amino Acids—Potential Biomarkers of Histological Features for MASLD in Pediatric Obesity. International Journal of Molecular Sciences 2026; 27(8) doi: 10.3390/ijms27083596
|